Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report

Severe epistaxis is often difficult to control in patients with hereditary hemorrhagic telangiectasia (HHT). Propranolol has been shown to have antiangiogenic properties in vitro and in vivo and is commonly us...

http://ift.tt/2xkaZOf